Publicaciones

Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels.

A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes.

Oral and intravenous 1'-cyano-substituted adenosine-like antivirals for early COVID-19.

"The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis".

Vagus Nerve Dysfunction in the Post-COVID-19 Condition: a pilot cross sectional study.

Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study.

Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.

HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective.

Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study.

Impact of obefazimod on viral persistence, inflammation, and immune activation in people with HIV on suppressive antiretroviral therapy.